Home
About Us
Portfolio Companies
Investor Relations
Contact
Overview
ProtAb
Enlivex Therapeutics
Cell Cure
KAHR Medical
BioMarCare Technologies
D-Pharm
Exit Strategy
Cell Cure
The page is under reconstruction
http://www.cellcureneurosciences.com
Founded:
2005
HBL's Holdings:
21%
Contact:
Charles S. Irving, Ph.D., CEO
POB 12247
Jerusalem 91121
Israel
+972-545-245-677
+972-2-642-9856
charles@cellcure.co.il
© Hadasit Bio-Holdings Ltd. All Rights Reserved.
Warranties and Disclaimers
.
Page Top
|
Print
|
Website By
Volle'